Litcius/Paper detail

Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results

Clotilde Gaible, Céline Narjoz, Marie‐Anne Loriot, Stéphane Roueff, Nicolas Pallet

2021Cancer Chemotherapy and Pharmacology17 citationsDOI

Topics & Concepts

DPYDDialysisMedicineEnd stage renal diseaseInternal medicinePeritoneal dialysisUrologyGastroenterologyPopulationHemodialysisPharmacogeneticsGenotypeBiologyGeneEnvironmental healthBiochemistryColorectal Cancer Treatments and StudiesNeonatal Health and BiochemistryBiochemical and Molecular Research
Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results | Litcius